| Q28274315 | 12- and 15-lipoxygenases in adipose tissue inflammation |
| Q30438017 | 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet |
| Q34298029 | 12-lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets |
| Q40504323 | 12-lipoxygenases and 12(S)-HETE: role in cancer metastasis |
| Q33507257 | 12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice |
| Q42157691 | A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid. |
| Q46417743 | A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor |
| Q41096149 | A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. |
| Q28397805 | Aberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis model |
| Q47899910 | Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. |
| Q41093078 | Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway |
| Q54355810 | Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats. |
| Q54186670 | Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice. |
| Q43065106 | Baicaleininhibits VSMCs proliferation via regulating LncRNAAK021954 gene expression |
| Q36535336 | Catalytic consumption of nitric oxide by 12/15- lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation |
| Q42510887 | Comparison of 12-lipoxygenase expression in vascular smooth muscle cells from old normotensive Wistar-Kyoto rats with spontaneously hypertensive rats |
| Q33745769 | Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC |
| Q43640298 | Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR. |
| Q51555423 | Deletion polymorphism of angiotensin-converting enzyme gene is associated with postprandial hyperglycaemia in individuals undergoing general check-up. |
| Q44249386 | Determination of urinary 12(S)-hydroxyeicosatetraenoic acid by liquid chromatography-tandem mass spectrometry with column-switching technique: sex difference in healthy volunteers and patients with diabetes mellitus |
| Q40628307 | Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice11See Editorial by Kasinath, p. 1918 |
| Q36576553 | Disparate effects of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid in vascular endothelial and smooth muscle cells and in cardiomyocytes. |
| Q42850400 | Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease |
| Q36932469 | Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. |
| Q42635527 | Downregulation of Angiotensin II-Induced 12-Lipoxygenase Expression and Cell Proliferation in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats by CCL5 |
| Q36844506 | Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes |
| Q28574130 | Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs |
| Q35129888 | Eicosanoids, β-cell function, and diabetes |
| Q51239324 | Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction. |
| Q93345082 | Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies |
| Q30306763 | Evidence that increased 12-lipoxygenase activity induces apoptosis in fibroblasts |
| Q30311121 | Evidence that increased 12-lipoxygenase expression impairs pancreatic beta cell function and viability |
| Q28296453 | Functional and pathological roles of the 12- and 15-lipoxygenases |
| Q44894343 | Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis |
| Q37692824 | Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management |
| Q37772395 | Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome |
| Q33578073 | IL-8/CXCL8 Upregulates 12-Lipoxygenase Expression in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats |
| Q30452047 | Increased 12/15-Lipoxygenase Enhances Cell Growth, Fibronectin Deposition, and Neointimal Formation in Response to Carotid Injury |
| Q34527211 | Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization |
| Q28281647 | Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway |
| Q30443785 | Inflammatory mechanisms of diabetic complications |
| Q42228384 | Inhibition of 12/15-Lipoxygenase Reduces Renal Inflammation and Injury in Streptozotocin-Induced Diabetic Mice |
| Q40687747 | Key role of P38 mitogen-activated protein kinase and the lipoxygenase pathway in angiotensin II actions in H295R adrenocortical cells |
| Q46468830 | Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells |
| Q36725904 | Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability |
| Q34138158 | Lipoxygenase in Human Tumor Cells |
| Q73091580 | Lipoxygenase inhibition decreases neointimal formation following vascular injury |
| Q28249730 | Mammalian lipoxygenases and their biological relevance |
| Q41161979 | Mechanisms of ANG II-induced mitogenic responses: role of 12-lipoxygenase and biphasic MAP kinase |
| Q37258870 | MicroRNAs and their role in progressive kidney diseases |
| Q34468392 | Minireview: 12-Lipoxygenase and Islet β-Cell Dysfunction in Diabetes |
| Q38744600 | P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection |
| Q34137628 | Pathological aspects of lipid peroxidation. |
| Q34743589 | Products of 12/15-lipoxygenase upregulate the angiotensin II receptor. |
| Q54956778 | Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. |
| Q44411450 | Reduced Growth Factor Responses in Vascular Smooth Muscle Cells Derived from 12/15-Lipoxygenase–Deficient Mice |
| Q36849525 | Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504 |
| Q44499434 | Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products |
| Q28583017 | Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors |
| Q60924006 | Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms |
| Q28572746 | Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation |
| Q71763053 | Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein 1 (AP-1) activity |
| Q36627809 | Role of lipoxygenase products in the effects of angiotensin II in the isolated aorta and perfused heart of the rat. |
| Q73910687 | Role of the lipoxygenase pathway in phenylephrine-induced vascular smooth muscle cell proliferation and migration |
| Q38938450 | Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction |
| Q21710694 | Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15) |
| Q38870510 | Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in monocytes/macrophages, attenuates high glucose-induced retinal leukostasis |
| Q42198780 | Temporal Changes in Skeletal Muscle Capillary Responses and Endothelial-Derived Vasodilators in Obesity-Related Insulin Resistance |
| Q30434996 | The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth |
| Q42515569 | The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angioten |
| Q38622658 | The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy |
| Q47620621 | Use of a hammerhead ribozyme with cationic liposomes to reduce leukocyte type 12-lipoxygenase expression in vascular smooth muscle |